Liu demonstrated that soluble Cytotoxic T-lymphocyte-associated antigen 4 (sCTLA-4) measured in 26 WHO II patients can discriminate among WHO grades and between glioma and control subjects. The gene discussed is CTLA4; the disease is glioma.